• Ivosenib 250mg (Ivosidenib) Quick View
    • Ivosenib 250mg (Ivosidenib) Quick View
    • ,
    • Ivosenib 250mg (Ivosidenib)

    • Ivosenib 250mg (Ivosidenib 250mg) is a groundbreaking medication designed to Treatment Acute Myeloid Leukemia (AML), particularly in patients with a specific genetic mutation called IDH1. This targeted therapy offers new hope for patients whose cancer is resistant to conventional treatments, providing a highly specialized approach that can transform the course of this aggressive blood cancer.  
    • Read more